Clinical Trial: Phase III Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06825416) titled 'Phase III Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty' on Feb. 09.

Brief Summary: The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Prevention of Arterial and Venous Thrombosis

Intervention: DRUG: SHR-2004 injection

SHR-2004 injection in low dose.

DRUG: SHR-2004 injection

SHR-2004 injection in high dose.

DRUG: Enoxaparin sodium injection

Enoxaparin sodium injection.

D...